SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071222
Filing Date
2022-11-10
Accepted
2022-11-10 16:30:51
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_oramedpharm.htm   iXBRL 10-Q 566736
2 CERTIFICATION f10q0922ex31-1_oramedpharm.htm EX-31.1 9578
3 CERTIFICATION f10q0922ex31-2_oramedpharm.htm EX-31.2 9333
4 CERTIFICATION f10q0922ex32-1_oramedpharm.htm EX-32.1 3583
5 CERTIFICATION f10q0922ex32-2_oramedpharm.htm EX-32.2 3347
  Complete submission text file 0001213900-22-071222.txt   3439054

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20220930.xsd EX-101.SCH 44173
7 XBRL CALCULATION FILE ormp-20220930_cal.xml EX-101.CAL 31723
8 XBRL DEFINITION FILE ormp-20220930_def.xml EX-101.DEF 180885
9 XBRL LABEL FILE ormp-20220930_lab.xml EX-101.LAB 383915
10 XBRL PRESENTATION FILE ormp-20220930_pre.xml EX-101.PRE 186527
40 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_oramedpharm_htm.xml XML 328652
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 221377790
SIC: 2834 Pharmaceutical Preparations